We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
42 hedge funds and large institutions have $108M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 42 → 42 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
7% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 15
8% less capital invested
Capital invested by funds: $118M → $108M (-$9.72M)
Holders
42
Holders Change
–
Holders Change %
0%
% of All Funds
0.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
3
Increased
14
Reduced
15
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.46M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$409K |
| 3 |
BlackRock
New York
|
+$90.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$70.1K |
| 5 |
LFG
Larson Financial Group
St Louis,
Missouri
|
+$60.8K |
